Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with PTGX: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
PTGX
Protagonist Therapeutics, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
PTGX
Protagonist Therapeutics, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only PTGX
2
JNJ
Janssen Biotech, Inc., a Johnson & Johnson company ("JNJ")
customer
TAK
Takeda Pharmaceuticals, Inc. ("Takeda")
customer
Role chip = supplier or customer
Source: SEC EDGAR
LLY
ELI Lilly & Co
Change
1,419.81
▲
+0.63%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
PTGX
Protagonist Therapeutics, Inc
Change
143.68
▲
+3.09%
Regular session
Nov 3 '26
Mkt cap
$9.0B
Revenue
$213M
Q2 FY26
Revenue
$46M
FY25
vs
Compare
Regular session
Nov 3 '26
LLY
ELI Lilly & Co
vs
PTGX
Protagonist Therapeutics, Inc
1,419.81
▲
+0.63%
Price
143.68
▲
+3.09%
$1.3T
Mkt cap
$9.0B
Q3 FY26
$24.4B
Revenue
$213M
Q2 FY26
FY25
$65.2B
Revenue
$46M
FY25
Change
Change
LLY
1,419.81
▲
+0.63%
vs
PTGX
143.68
▲
+3.09%
Regular session
Nov 3 '26